HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients

Go back to HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients
BIOTELEMETRY (NASDAQ: BEAT) Delayed: 0.40 -0.01 (2.44%)
Previous Close $0.41    52 Week High $21.68 
Open $0.41    52 Week Low $8.74 
Day High $0.41    P/E N/A 
Day Low $0.39    EPS $-0.46 
Volume 592,735